Volitionrx (VNRX) Non-Current Deffered Revenue (2024 - 2026)
Volitionrx's (VNRX) quarterly Non-Current Deffered Revenue came in at $21.9 million in Q4 2025, down 3.2% YoY from $22.7 million in Q4 2024, and little changed on a QoQ basis from $22.0 million in Q3 2025.
Volitionrx (VNRX) Non-Current Deffered Revenue (2024 - 2026) Analysis & Trends
Volitionrx (VNRX) has 2 years of Non-Current Deffered Revenue data on file, last reported at $21.9 million in Q4 2025.
- Quarterly Non-Current Deffered Revenue fell 3.2% year-over-year to $21.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $21.9 million (down 3.2% YoY) and the FY2025 annual result came in at $21.9 million, down 3.2% from the prior year.
- Non-Current Deffered Revenue was little changed at $21.9 million in Q4 2025, from $22.0 million in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $22.7 million in Q4 2024 to a low of $21.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 539.34 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | - |
| 10 | Volitionrx | 1.13 Mn | -1.66 Mn | - | 21.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.23 Mn |
| Dec 31, 2025 | 21.94 Mn |
| Sep 30, 2025 | 22.03 Mn |
| Jun 30, 2025 | 22.66 Mn |
| Mar 31, 2025 | 22.66 Mn |
| Dec 31, 2024 | 22.66 Mn |